Measurement of left ventricular mass in vivo using gated nuclear magnetic resonance imaging
MS Florentine,
CL Grosskreutz,
W Chang,
JA Hartnett,
VD Dunn,
JC Ehrhardt,
Fleagle SR,
SM Collins,
ML Marcus,
and
DJ Skorton
Alterations of left ventricular mass occur in a variety of congenital and acquired heart diseases. In vivo determination of left ventricular mass, using several different techniques, has been previously reported. Problems inherent in some previous methods include the use of ionizing radiation, complicated geometric assumptions and invasive techniques. We tested the ability of gated nuclear magnetic resonance imaging to determine in vivo left ventricular mass in animals. By studying both dogs (n = 9) and cats (n = 2) of various sizes, a broad range of left ventricular mass (7 to 133 g) was examined. With a 0.5 tesla superconducting nuclear magnetic resonance imaging system the left ventricle was imaged in the transaxial plane and multiple adjacent 10 mm thick slices were obtained. Endocardial and epicardial edges were manually traced in each computer-displayed image. The wall area of each image was determined by computer and the areas were summed and multiplied by the slice thickness and the specific gravity of muscle, providing calculated left ventricular mass. Calculated left ventricular mass was compared with actual postmortem left ventricular mass using linear regression analysis. An excellent relation between calculated and actual mass was found (r = 0.95; SEE = 13.1 g; regression equation: magnetic resonance mass = 0.95 X actual mass + 14.8 g). Intraobserver and interobserver reproducibility were also excellent (r = 0.99). Thus, gated nuclear magnetic resonance imaging can accurately determine in vivo left ventricular mass in anesthetized animals.
This article has been cited by other articles:

|
 |

|
 |
 
E. Agabiti-Rosei, M. L. Muiesan, and M. Salvetti
Review: New approaches to the assessment of left ventricular hypertrophy
Therapeutic Advances in Cardiovascular Disease,
December 1, 2007;
1(2):
119 - 128.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Schlosser, K. Pagonidis, C. U. Herborn, P. Hunold, K.-U. Waltering, T. C. Lauenstein, and J. Barkhausen
Assessment of Left Ventricular Parameters Using 16-MDCT and New Software for Endocardial and Epicardial Border Delineation
Am. J. Roentgenol.,
March 1, 2005;
184(3):
765 - 773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report
Eur. Heart J.,
November 1, 2004;
25(21):
1940 - 1965.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Alfakih, K. Walters, T. Jones, J. Ridgway, A. S. Hall, and M. Sivananthan
New Gender-Specific Partition Values for ECG Criteria of Left Ventricular Hypertrophy: Recalibration Against Cardiac MRI
Hypertension,
August 1, 2004;
44(2):
175 - 179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. C. Moon, C. H. Lorenz, J. M. Francis, G. C. Smith, and D. J. Pennell
Breath-hold FLASH and FISP Cardiovascular MR Imaging: Left Ventricular Volume Differences and Reproducibility
Radiology,
June 1, 2002;
223(3):
789 - 797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Myerson, N. G. Bellenger, and D. J. Pennell
Assessment of Left Ventricular Mass by Cardiovascular Magnetic Resonance
Hypertension,
March 1, 2002;
39(3):
750 - 755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. van der Wall, H. W. Vliegen, A. de Roos, and A. V.G. Bruschke
Magnetic Resonance Imaging in Coronary Artery Disease
Circulation,
November 1, 1995;
92(9):
2723 - 2739.
[Abstract]
[Full Text]
|
 |
|
|